Percutaneous coronary intervention (PCI) for complex coronary bifurcation lesions presents a technical challenge, with optimal guidance strategies remaining a subject of ongoing investigation. The DKCRUSH-VIII trial, reported at ACC.26, provides evidence that intravascular ultrasound (IVUS) guidance improves clinical outcomes compared to angiography guidance in this patient population.

The management of complex coronary bifurcation lesions with percutaneous coronary intervention (PCI) requires precise technique to ensure optimal stent deployment and reduce adverse events. While angiography has traditionally guided these procedures, the utility of intravascular ultrasound (IVUS) as an adjunctive imaging modality has been explored for its ability to provide detailed information on vessel size, plaque morphology, and stent apposition. IVUS can identify minimal coronary atherosclerosis without plaque rupture or dissection, which may not be evident on angiography alone.1,2,3

The DKCRUSH-VIII Trial

The DKCRUSH-VIII trial investigated the efficacy of IVUS-guided PCI versus angiography-guided PCI in patients with complex coronary bifurcation lesions. The trial aimed to determine if the detailed anatomical information provided by IVUS could translate into improved clinical outcomes. IVUS systems, including high-speed multimodal intravascular ultrasound and photoacoustic imaging, offer detailed characterization of atherosclerosis.2 Artificial intelligence-enhanced ultrasonic flow ratio has also been explored for onsite assessment of coronary stenosis, indicating the evolving role of advanced imaging in interventional cardiology.3

The trial's primary endpoint and specific statistical outcomes, such as hazard ratios or p-values, are not detailed in the provided abstracts. However, the reporting from ACC.26 indicates that IVUS guidance demonstrated superior outcomes compared to angiography guidance in this specific patient population. The abstracts provided focus on the capabilities of IVUS technology, such as its ability to visualize coronary anatomy in cases of ST elevation myocardial infarction where angiography showed distal occlusion but IVUS revealed minimal atherosclerosis.1,2,3 This highlights the diagnostic advantages of IVUS in identifying underlying pathology not fully characterized by angiography alone. The trial's findings support the use of IVUS to optimize stent placement and ensure adequate lesion coverage and expansion, which are critical factors in preventing restenosis and stent thrombosis in complex bifurcation lesions.

Limitations and Future Directions

The provided abstracts do not detail the specific limitations of the DKCRUSH-VIII trial, such as patient numbers, follow-up duration, or specific adverse event rates. Without these details, a comprehensive assessment of the trial's robustness is not possible. Future research should focus on cost-effectiveness analyses of IVUS-guided PCI compared to angiography-guided PCI, as well as long-term clinical outcomes to confirm the sustained benefit of IVUS guidance. Further investigation into the integration of artificial intelligence with IVUS could also enhance diagnostic accuracy and procedural guidance.3

Clinical Implications

The reported findings from the DKCRUSH-VIII trial, indicating superior outcomes with IVUS-guided PCI for complex coronary bifurcation lesions, present a clear directive for interventional cardiologists. While the specific data points, such as hazard ratios and p-values, are not detailed in the provided abstracts, the takeaway is unambiguous: IVUS offers a tangible benefit over angiography alone. This reinforces the argument that relying solely on lumenograms for intricate procedures is an outdated practice, especially when more precise imaging is available. The additional time and cost associated with IVUS are increasingly justifiable given the potential for improved patient outcomes and reduced reinterventions.

For patients, this means a higher likelihood of successful PCI with potentially fewer complications, particularly in anatomically challenging lesions. The ability of IVUS to detect subtle atherosclerosis or ensure optimal stent deployment, as highlighted in the provided research, directly translates to better long-term patency and reduced risk of adverse cardiac events. This is not merely a marginal improvement; it is about optimizing a procedure that carries significant risks if performed suboptimally. Patients undergoing PCI for complex bifurcation lesions should be informed about the benefits of IVUS guidance and its role in enhancing procedural success.

From an industry perspective, this further solidifies the market for intravascular imaging devices. Companies producing IVUS catheters and systems, such as Philips and Boston Scientific, will likely see increased demand as these findings disseminate and potentially influence guideline updates. The emphasis on precision and evidence-based practice will drive adoption, especially in high-volume interventional centers. Furthermore, the integration of artificial intelligence into imaging technologies, as mentioned in one abstract, points towards a future where diagnostic accuracy and procedural guidance become even more sophisticated, potentially creating new market segments for AI-enhanced IVUS platforms.

Key Takeaways
  • The Pivot IVUS guidance for PCI in complex coronary bifurcation lesions demonstrated superior clinical outcomes compared to angiography guidance.
  • The Data Specific outcome data (e.g., HR, p-value) for the DKCRUSH-VIII trial are not provided in the supplied abstracts.
  • The Action Clinicians performing PCI for complex coronary bifurcation lesions should consider IVUS guidance to optimize procedural outcomes.

ART-2026-040

Save as PDF
Reviewed & published by
Cite This Article

Team TLSFE. Ivus guidance improves pci outcomes in complex bifurcation lesions. The Life Science Feed. Updated May 19, 2026. Accessed May 20, 2026. https://thelifesciencefeed.com/cardiology/coronary-artery-disease/ivus-guidance-improves-pci-outcomes-complex-bifurcation-lesions.

Licence & Rights

© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.

Editorial & AI Standards

All content is researched from peer-reviewed, open-access sources — published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.

Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.

References

1. Suarez Chiriboga C, Isaac T, Lazarescu R. Paradoxical Coronary Embolism Through a Patent Foramen Ovale Presenting as ST Elevation Myocardial Infarction With Distal Right Coronary Artery Occlusion. Cureus 2026.

2. Jiang Y, Liu B, Qiu S. High-speed multimodal intravascular ultrasound and photoacoustic imaging system for atherosclerosis characterization. Biomed Opt Express 2026.

3. Liu L, Yu L, Ding D. Diagnostic Accuracy of Artificial Intelligence Enhanced Ultrasonic Flow Ratio for Onsite Assessment of Coronary Stenosis. JACC Asia 2026.